✦ LIBER ✦

Optimizing the management of HER2-negative metastatic breast cancer with capecitabine (Xeloda)

✍ Scribed by Robert Leonard; David Miles; Peter Reichardt; Chris Twelves

Book ID: 114473583
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 159 KB
Volume: 31
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2004.07.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current approaches to the management of

Current approaches to the management of Her2-negative metastatic breast cancer

✍ Keerthi Gogineni; Angela DeMichele 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 296 KB

Optimizing treatment of HER2-positive me

Optimizing treatment of HER2-positive metastatic breast cancer

✍ Alison L. Jones; Brian Leyland-Jones 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 141 KB

446 Quality of life (QoL) in patients wi

446 Quality of life (QoL) in patients with metastatic breast cancer (MBC) treated with capecitabine (Xeloda)

✍ G. Segalla; C.T. Oliveira; S. Lago; R. Ribeiro; R. Guimarães; S. Cabral; G. Letc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A retrospective study evaluating a fixed

A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer

✍ Ambros, Tadeu; Zeichner, Simon B.; Zaravinos, John; Montero, Alberto J.; Ahn, Eu 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 202 KB

Sorafenib in Combination With Capecitabi

Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer

✍ Baselga, J.; Segalla, J. G. M.; Roche, H.; del Giglio, A.; Pinczowski, H.; Cirue 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 177 KB

Management of HER-2/neu-positive metasta

Management of HER-2/neu-positive metastatic breast cancer

✍ Ahmad Awada; Martine J. Piccart-Gebhart 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 299 KB